Autophagy: A new target for advanced papillary thyroid cancer therapy

Surgery

Volumn 146, Issue 6, 2009, Pages 1208-1214

  Lin, Chi Iou ^a   Whang, Edward E ^a   Abramson, Michael A ^a   Jiang, Xiaofeng ^b   Price, Brendan D ^b   Donner, David B ^c   Moore Jr , Francis D ^a   Ruan, Daniel T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; DOXORUBICIN; MICROTUBULE PROTEIN; PROTEIN LC3 I; PROTEIN LC3 II; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER THERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIOSENSITIVITY; THYROID CANCER;

ADENINE; ANTIBIOTICS, ANTINEOPLASTIC; AUTOPHAGY; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; RADIATION TOLERANCE; THYROID NEOPLASMS;

EID: 70549107878     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.09.019     Document Type: Article

References (33)

1. Prasad N.B., Somervell H., Tufano R.P., Dackiw A.P., Marohn M.R., Califano J.A., et al. Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clin Cancer Res 14 (2008) 3327-3337
2. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-2648.
3. Mazzaferri E.L., and Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97 (1994) 418-428
4. Matuszczyk A., Petersen S., Bockisch A., Gorges R., Sheu S.Y., Veit P., et al. Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epithelium. Horm Metab Res 40 (2008) 210-213
5. Kelekar A. Autophagy. Ann N Y Acad Sci 1066 (2005) 259-271
6. Klionsky D.J., and Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 290 (2000) 1717-1721
7. Meijer A.J., and Codogno P. Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 36 (2004) 2445-2462
8. Mathew R., and White E. Why sick cells produce tumors: the protective role of autophagy. Autophagy 3 (2007) 502-505
9. Reggiori F., and Klionsky D.J. Autophagosomes: biogenesis from scratch?. Curr Opin Cell Biol 17 (2005) 415-422
10. Paglin S., Hollister T., Delohery T., Hackett N., McMahill M., Sphicas E., et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61 (2001) 439-444
11. Lambert L.A., Qiao N., Hunt K.K., Lambert D.H., Mills G.B., Meijer L., et al. Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68 (2008) 7966-7974
12. Muñoz-Gámez J.A., Rodríguez-Vargas J.M., Quiles-Pérez R., Aguilar-Quesada R., Martín-Oliva D., de Murcia G., et al. PARP-1 is involved in autophagy induced by DNA damage. Autophagy 5 (2009) 61-74
13. Yeung S.C., She M., Yang H., Pan J., Sun L., and Chaplin D. Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model. J Clin Endocrinol Metab 92 (2007) 2902-2909
14. Mizushima N., and Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 3 (2007) 542-545
15. Cadwell K., Liu J.Y., Brown S.L., Miyoshi H., Loh J., Lennerz J.K., et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456 (2008) 259-263
16. Seglen P.O., and Gordon P.B. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 79 (1982) 1889-1892
17. Lin C.I., Whang E.E., Abramson M.A., Donner D.B., Bertagnolli M.M., Moore Jr. F.D., et al. Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells. Biochem Biophys Res Commun 379 (2009) 626-631
18. Ahmad M., and Shi Y. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention. Oncogene 19 (2000) 3363-3371
19. Rao A.S., Kremenevskaja N., von Wasielewski R., Jakubcakova V., Kant S., Resch J., et al. Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer. J Clin Endocrinol Metab 91 (2006) 159-168
20. Mills K.R., Reginato M., Debnath J., Queenan B., and Brugge J.S. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc Natl Acad Sci U S A 101 (2004) 3438-3443
21. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., et al. LC3, a mammalian homologue of yeast Apg8 p, is localized in autophagosome membranes after processing. EMBO J 19 (2000) 5720-5728
22. Thorburn A. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 13 (2008) 1-9
23. Gozuacik D., and Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23 (2004) 2891-2906
24. Crighton D., Wilkinson S., O'Prey J., Syed N., Smith P., Harrison P.R., et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126 (2006) 121-134
25. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 (2005) 927-939
26. Feng W., Huang S., Wu H., and Zhang M. Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1. J Mol Biol 372 (2007) 223-235
27. Arola O.J., Saraste A., Pulkki K., Kallajoki M., Parvinen M., and Voipio-Pulkki L.M. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 60 (2000) 1789-1792
28. Yousefi S., Perozzo R., Schmid I., Ziemiecki A., Schaffner T., Scapozza L., et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 8 (2006) 1124-1132
29. Akar U., Chaves-Reyez A., Barria M., Tari A., Sanguino A., Kondo Y., et al. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 4 (2008) 669-679
30. Albert J.M., Kim K.W., Cao C., and Lu B. Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer. Mol Cancer Ther 5 (2006) 1183-1189
31. Kim K.W., Mutter R.W., Cao C., Albert J.M., Freeman M., Hallahan D.E., et al. Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J Biol Chem 281 (2006) 36883-36890
32. Kim K.W., Hwang M., Moretti L., Jaboin J.J., Cha Y.I., and Lu B. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 4 (2008) 659-668
33. Cao C., Subhawong T., Albert J.M., Kim K.W., Geng L., Sekhar K.R., et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res 66 (2006) 10040-10047